Category: Clinical Breakthroughs
-
Lakeside Discovery Supports Northwestern Lab to Treat Polycystic Kidney Disease
Lakeside Discovery, LLC, the collaboration between Northwestern University and Deerfield Management, will support the laboratory of Paul DeCaen, PhD in a multi-year partnership to advance new therapies for genetically driven polycystic kidney disease.
-
The XX/XY Factor
A massive trove of information produced in a Northwestern-led study will lay the groundwork for understanding sex-related differences in health and disease for decades to come.
-
No Pain, No Gain in Exercise for Peripheral Artery Disease
A Northwestern Medicine study has shown that a high-intensity home-based walking exercise program improved walking ability in people with peripheral artery disease.
-
‘Sweat Sticker’ Diagnoses Cystic Fibrosis on The Skin in Real Time
Developed by Northwestern scientists, a novel skin-mounted sticker that absorbs sweat and then changes color can provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.
-
Examining Rare Neurological Complications of COVID-19 in Children
The largest study to date of neurological manifestations of COVID-19 in children demonstrated patterns in the rare complications seen among pediatric patients.
-
Gastrointestinal Surgical Technique Linked to Lower Recurrence of Cancer
Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.
-
Cancer Drug May Have Potential for Pain Relief
Scientists discovered a previously unknown receptor site in a voltage-gated sodium channel, suggesting that a commonly-used cancer drug could be used to target this channel and relieve pain.
-
Evaluating Perioperative Chemotherapy for Pancreatic Cancer
Perioperative chemotherapy treatment did not improve overall survival for patients with resectable pancreatic cancer, according to a recent Northwestern Medicine clinical trial.
-
Northwestern Investigators Explore COVID-19 Treatments
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
-
Identifying Therapeutic Targets for B-cell Acute Lymphoblastic Leukemia
Northwestern Medicine investigators have identified a protein kinase called DYRK1A and its downstream substrates as potential therapeutic targets for treating pediatric patients with B-cell acute lymphoblastic leukemia.
